Literature DB >> 18069127

A novel TRH analog, Glp-Asn-Pro-D-Tyr-D-TrpNH2, binds to [3H][3-Me-His2]TRH-labelled sites in rat hippocampus and cortex but not pituitary or heterologous cells expressing TRHR1 or TRHR2.

Nicola Hogan1, Kathy M O'Boyle, Patricia M Hinkle, Julie A Kelly.   

Abstract

Glp-Asn-Pro-D-Tyr-D-TrpNH(2) is a novel synthetic peptide that mimics and amplifies central actions of thyrotropin-releasing hormone (TRH) in rat without releasing TSH. The aim of this study was to compare the binding properties of this pentapeptide and its all-L counterpart (Glp-Asn-Pro-Tyr-TrpNH(2)) to TRH receptors in native rat brain tissue and cells expressing the two TRH receptor subtypes identified in rat to date, namely TRHR1 and TRHR2. Radioligand binding studies were carried out using [(3)H][3-Me-His(2)]TRH to label receptors in hippocampal, cortical and pituitary tissue, GH4 pituitary cells, as well as CHO cells expressing TRHR1 and/or TRHR2. In situ hybridization studies suggest that cortex expresses primarily TRHR2 mRNA, hippocampus primarily TRHR1 mRNA and pituitary exclusively TRHR1 mRNA. Competition experiments showed [3-Me-His(2)]TRH potently displaced [(3)H][3-Me-His(2)]TRH binding from all tissues/cells investigated. Glp-Asn-Pro-D-Tyr-D-TrpNH(2) in concentrations up to 10(-5)M did not displace [(3)H][3-Me-His(2)]TRH binding to membranes derived from GH4 cells or CHO-TRHR1 cells, consistent with its lack of binding to pituitary membranes and TSH-releasing activity. Similar results were obtained for the corresponding all-L peptide. In contrast, both pentapeptides displaced binding from rat hippocampal membranes (pIC(50) Glp-Asn-Pro-D-Tyr-D-TrpNH(2): 7.7+/-0.2; pIC(50) Glp-Asn-Pro-Tyr-TrpNH(2): 6.6+/-0.2), analogous to cortical membranes (pIC(50) Glp-Asn-Pro-D-Tyr-D-TrpNH(2): 7.8+/-0.2; pIC(50) Glp-Asn-Pro-Tyr-TrpNH(2): 6.6+/-0.2). Neither peptide, however, displaced [(3)H][3-Me-His(2)]TRH binding to CHO-TRHR2. Thus, this study reveals for the first time significant differences in the binding properties of native and heterologously expressed TRH receptors. Also, the results raise the possibility that Glp-Asn-Pro-D-Tyr-D-TrpNH(2) is not displacing [(3)H][3-Me-His(2)]TRH from a known TRH receptor in rat cortex, but rather a hitherto unidentified TRH receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18069127      PMCID: PMC2990697          DOI: 10.1016/j.neulet.2007.11.013

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer.

Authors:  K M Kroeger; A C Hanyaloglu; R M Seeber; L E Miles; K A Eidne
Journal:  J Biol Chem       Date:  2001-01-18       Impact factor: 5.157

Review 2.  G-protein-coupled receptor oligomerization and its potential for drug discovery.

Authors:  Susan R George; Brian F O'Dowd; Samuel P Lee
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

Review 3.  Thyrotropin-releasing hormone receptors -- similarities and differences.

Authors:  Y Sun; X Lu; M C Gershengorn
Journal:  J Mol Endocrinol       Date:  2003-04       Impact factor: 5.098

4.  TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1.

Authors:  B F O'Dowd; D K Lee; W Huang; T Nguyen; R Cheng; Y Liu; B Wang; M C Gershengorn; S R George
Journal:  Mol Endocrinol       Date:  2000-01

5.  Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.

Authors:  H Heuer; M K Schäfer; D O'Donnell; P Walker; K Bauer
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

6.  Dimerization and phosphorylation of thyrotropin-releasing hormone receptors are modulated by agonist stimulation.

Authors:  Chang-Cheng Zhu; Laurie B Cook; Patricia M Hinkle
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

7.  Characterization and functional expression of cDNAs encoding thyrotropin-releasing hormone receptor from Xenopus laevis.

Authors:  Isabelle Bidaud; Philippe Lory; Pierre Nicolas; Marc Bulant; Ali Ladram
Journal:  Eur J Biochem       Date:  2002-09

8.  Pharmacologically distinct binding sites in rat brain for [3H]thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine(2)]TRH.

Authors:  Julie A Kelly; Gillian R Slator; Kathy M O'Boyle
Journal:  Biochem Pharmacol       Date:  2002-06-15       Impact factor: 5.858

9.  Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2.

Authors:  Aylin C Hanyaloglu; Ruth M Seeber; Trudy A Kohout; Robert J Lefkowitz; Karin A Eidne
Journal:  J Biol Chem       Date:  2002-10-21       Impact factor: 5.157

10.  Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides.

Authors:  Patricia M Hinkle; A Eugene Pekary; Shayani Senanayaki; Albert Sattin
Journal:  Brain Res       Date:  2002-05-10       Impact factor: 3.252

View more
  3 in total

1.  Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.

Authors:  James D Boghosian; Anita Luethy; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2018-04-19       Impact factor: 4.030

2.  Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice.

Authors:  Chhuttan L Meena; Shubdha Ingole; Satyendra Rajpoot; Avinash Thakur; Prajwal P Nandeker; Abhay T Sangamwar; Shyam S Sharma; Rahul Jain
Journal:  RSC Adv       Date:  2015-06-23       Impact factor: 3.361

3.  Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.

Authors:  Nanthakumar Thirunarayanan; Eshel A Nir; Bruce M Raaka; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2012-12-11       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.